Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Month: November 2022

Touchlight receives funding to develeop DNA vaccine platform

Bill & Melinda Gates Foundation grant will boost potential of nanoparticle-formulated doggybone DNA

November 29, 2022 Uncategorized

Immutep in clinical trail collaboration with Merck KGaA and Pfizer

Research will focus on eftilagimod alpha and avelumab for the treatment of urothelial cancer

November 29, 2022 Uncategorized

Ministers plan to replicate vaccine task force for cancer, obesity, mental health, and addiction

The UK government has pledged to replicate the blueprint it used for its covid vaccine rollout to tackle […]

November 28, 2022 Uncategorized

Almirall joins project to allow study participants to use trial data

Project involves 27 partners including patient associations, hospitals and universities

November 28, 2022 Uncategorized

C4XD signs NRF2 Activator deal with AstraZeneca

C4XD will receive milestone payments worth up to $16m ahead of the first clinical trial

November 28, 2022 Uncategorized

Measuring organ development

Researchers from Dresden and Vienna reveal link between connectivity of three-dimensional structures in tissues and the emergence of […]

November 28, 2022 Uncategorized

WHO-recommended hand disinfectants inactivate monkeypox viruses

A research team from the virology departments of Ruhr University Bochum, Germany, and the Heinrich Heine University Düsseldorf, […]

November 28, 2022 Uncategorized

Advances in diagnosis and treatment of testicular cancer

AbstractTesticular cancer is a curable cancer. The success of physicians in curing the disease is underpinned by multidisciplinary […]

November 28, 2022 US, State of the Art

Retracted papers originating from paper mills: cross sectional study

AbstractObjectivesTo describe retracted papers originating from paper mills, including their characteristics, visibility, and impact over time, and the […]

November 28, 2022 Uncategorized

NICE’s new methods: putting innovation first, but at what cost?

Deciding when a new drug merits funding and when it does not—often to the displeasure of clinicians and […]

November 28, 2022 Uncategorized

Posts navigation

Posts pagination

« Previous 1 … 3 4 5 … 31 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy